-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BHRRbcjGsX1jcb+qaM+s2Hlo4yDQ0bkhhB7a6ShssSTVkZ0oK861HZvMUrcyXyx0 QG7dL0bbeHRvyOSAEFsKDw== 0001440766-10-000001.txt : 20100301 0001440766-10-000001.hdr.sgml : 20100301 20100301161248 ACCESSION NUMBER: 0001440766-10-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100225 FILED AS OF DATE: 20100301 DATE AS OF CHANGE: 20100301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dingivan Christine A CENTRAL INDEX KEY: 0001440766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 10644645 MAIL ADDRESS: STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC. STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-02-25 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001440766 Dingivan Christine A 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 EVP/Chief Medical Officer Stock Option (to buy) 21.17 2010-02-25 4 A 0 40000 0 A 2011-02-25 2020-02-25 Common Stock 40000 40000 D Stock Options (to buy) 26.64 2010-02-18 2019-02-18 Common Stock 30000 30000 D Stock Options (to buy) 20.64 2009-11-20 2018-11-20 Common Stock 7500 7500 D Stock Options (to buy) 39.01 2009-10-03 2018-10-03 Common Stock 7500 7500 D Stock Options (to buy) 37.93 2009-07-28 2018-07-28 Common Stock 90000 90000 D The options will vest in equal increments of 1/3 on February 25, 2011, February 25, 2012 and February 25, 2013. The options will vest in equal increments of 1/3 on February 18, 2010, February 18, 2011 and February 18, 2012. The options will vest in equal increments of 1/3 on November 20, 2009, November 20, 2010 and November 20, 2011. The options will vest in equal increments of 1/3 on October 3, 2009, October 3, 2010 and October 3, 2011. The options vest in equal increments of 1/3 on July 28, 2009, July 28, 2010 and July 28, 2011. Lisa C. Noecker attorney-in-fact for Christine A. Dingivan 2010-03-01 -----END PRIVACY-ENHANCED MESSAGE-----